Research Directory

An unusual year begets unusual returns

Read more

Biotechs are energised - at least for now

Read more

How Britain champions medical innovation

Read more

Stocks mostly stable amid the fireworks

Read more

European biotechs rise in March quarter

Read more

Banner year for biotechs

Read more

European biotechs soar

Read more

Advanced medical therapies attract investors

Read more

European biotechs match gains in US market

Read more

2012 was the year of the antibody developer

Read more